Adial Pharmaceuticals Announces Approval to Commence Landmark ONWARD(TM) Pivotal Phase 3 Trial in Poland
Achievement of Poland Approval an Important Milestone in Advancement of Trial Trial Progress Accelerates as Host Countries Reopen Following COVID-19...